Regulatory And Methodical Aspects Of Pre-Clinical And Clinical Studies Of Feed Additives For Animals

D.R. Kargopoltseva(1), K.L. Kryshen(1), M.N. Makarova(2), V.G. Makarov(1) 1-Ltd «Institute of pharmacy» Kuzmolovsky, Vsevolozhsky Dist., Leningrad Region, 3, Zavodskaya St., Build. 245, 188663, Russia; 2-RPА «Нoum оf Pharmacy» Kuzmolovsky, Vsevolozhsky Dist., Leningrad Region, 3, Zavodskaya St., Build. 245, 188663, Russia Е-mail: agasieva.dr@doclinika.ru

Abstract

In recent years, due to the development of agriculture and the increase in the number of pet owners, there is a rapid development of veterinary medicine not only in the Russian Federation, but throughout the world. Along with the development of veterinary medicine, there is also the improvement of veterinary pharmaceutics, which develops and produces more and more veterinary drugs and feed additives for animals. For new feed additives for animals, as well as medicines for humans, is required to pass state registration to enter the market, for which a package of documents is provided. One of the most important documents is the results of preclinical and clinical research. However, if there are many normative documents for medicines for humans in the Russian Federation that describe the scope and scheme of research, no such documents and instructions have been developed to date with feed additives. Therefore, the development of regulatory documents harmonized with international requirements is required. In this paper, the main international regulatory requirements for preclinical and clinical studies of feed additives for animals are reviewed. Based on the results of the studies, it can be concluded that this model is simple, uncomplicated and quite informative.

References

  1. Proekt Administrativnogo reglamenta predostavleniya Rossel`hoznadzorom gosudarstvennoy uslugi po gosudarstvennoy registracii kormovyh dobavok Prikaz Minsel`hoza RF №48 ot 1 aprelya 2005 g. «Ob utverzhdenii Pravil gosudarstvennoy registracii lekarstvennyh sredstv dlya zhivotnyh i kormovyh dobavok».
  2. Prikaz Minsel`hoza RF №48 ot 01.04.2005 «Ob utverzhdenii Pravil gosudarstvennoy registracii lekarstvennyh sredstv dlya zhivotnyh i kormovyh dobavok».
  3. Prikaz Minsel`hoza RF №101 ot 06.03.2018 «Ob utverzhdenii pravil provedeniya doklinicheskogo issledovaniya lekarstvennogo sredstva dlya veterinarnogo primeneniya, klinicheskogo issledovaniya lekarstvennogo preparata dlya veterinarnogo primeneniya, issledovaniya bioe`kvivalentnosti lekarstvennogo preparata dlya veterinarnogo primeneniya».
  4. Reglament (ES) №1831/2003 Evropeyskogo Parlamenta i Soveta ot 22 sentyabrya 2003 g. o dobavkah, primenyaemyh v pitanii zhivotnyh.
  5. Reglament ES 429/2009 ot 25 aprelya 2008 g. o podrobnyh pravilah primeneniya Reglamenta (ES) № 1831/2003 Evropeyskogo Parlamenta i Soveta po podgotovke i predstavleniyu zayavok, a takzhe provedeniya ocenki i vydachi razresheniy po kormovym dobavkam.
  6. Direktiva 2010/63/EU Evropeyskogo Parlamenta i Sovetom Evropeyskogo Soyuza ot 22.09.2010 g. po ohrane zhivotnyh, ispol`zuemyh v nauchnyh celyah (Directive 2010/63/EU of the European Parliament and of the Council of 22Sep2010 on the protection of animals used for scientific purposes).
  7. OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring. E`lektronnyy resurs. http://dx.doi.org/10.1787/2077785x.
  8. Lekarstvennye sredstva dlya medicinskogo primeneniya. Rukovodstvo po planirovaniyu doklinicheskih issledovaniy bezopasnosti s cel`yu posleduyushhego provedeniya klinicheskih issledovaniy i registracii lekarstvennyh sredstv. GOST R 56701-2015. Vved. 01-07-2016. M.: Standartinform, 2016.
  9. Lekarstvennye sredstva dlya medicinskogo primeneniya. Issledovanie genotoksichnosti i interpretaciya poluchennyh dannyh: GOST R 57130-2016. Vved. 01-05-2016. M.: Standartinform, 2016.

You may be interested